Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 9 | 2019 | 806 | 1.640 |
Why?
|
Ventricular Remodeling | 26 | 2011 | 1223 | 1.560 |
Why?
|
Matrix Metalloproteinases | 14 | 2011 | 388 | 1.350 |
Why?
|
Matrix Metalloproteinase 9 | 9 | 2010 | 630 | 0.830 |
Why?
|
Myocardial Contraction | 12 | 2009 | 1502 | 0.760 |
Why?
|
Myocardium | 23 | 2011 | 4639 | 0.750 |
Why?
|
Myocardial Infarction | 23 | 2011 | 11655 | 0.690 |
Why?
|
Ventricular Function, Left | 15 | 2011 | 3704 | 0.660 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 9 | 2011 | 98 | 0.640 |
Why?
|
Matrix Metalloproteinase 2 | 10 | 2010 | 459 | 0.580 |
Why?
|
Heart Arrest, Induced | 4 | 2006 | 356 | 0.570 |
Why?
|
Matrix Metalloproteinase 14 | 7 | 2011 | 59 | 0.560 |
Why?
|
Glutens | 2 | 2015 | 236 | 0.520 |
Why?
|
Myocardial Reperfusion Injury | 5 | 2009 | 473 | 0.410 |
Why?
|
Endopeptidases | 1 | 2015 | 770 | 0.380 |
Why?
|
Immunomodulation | 1 | 2015 | 540 | 0.380 |
Why?
|
Diet, Gluten-Free | 4 | 2019 | 277 | 0.370 |
Why?
|
Myocytes, Cardiac | 8 | 2010 | 1611 | 0.370 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 4 | 2005 | 146 | 0.350 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8509 | 0.340 |
Why?
|
Swine | 21 | 2011 | 5869 | 0.340 |
Why?
|
Duodenum | 1 | 2012 | 480 | 0.340 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2010 | 239 | 0.330 |
Why?
|
Endotoxins | 1 | 2010 | 524 | 0.310 |
Why?
|
Endothelin-1 | 2 | 2006 | 302 | 0.300 |
Why?
|
Finite Element Analysis | 1 | 2010 | 427 | 0.300 |
Why?
|
Models, Cardiovascular | 2 | 2010 | 958 | 0.290 |
Why?
|
Heart Conduction System | 2 | 2010 | 1001 | 0.290 |
Why?
|
Oligopeptides | 4 | 2015 | 1187 | 0.280 |
Why?
|
Aorta, Thoracic | 6 | 2010 | 1050 | 0.280 |
Why?
|
Fibrinolysin | 3 | 2011 | 130 | 0.270 |
Why?
|
Aortic Aneurysm, Thoracic | 6 | 2010 | 682 | 0.270 |
Why?
|
Aprotinin | 3 | 2011 | 89 | 0.260 |
Why?
|
Animals, Newborn | 1 | 2010 | 2654 | 0.250 |
Why?
|
Cytokines | 5 | 2017 | 7219 | 0.250 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2005 | 137 | 0.250 |
Why?
|
Protein Kinase C | 2 | 2006 | 1196 | 0.240 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7570 | 0.240 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2004 | 68 | 0.240 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2010 | 810 | 0.240 |
Why?
|
Electric Stimulation Therapy | 1 | 2010 | 608 | 0.240 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 950 | 0.230 |
Why?
|
Heart-Assist Devices | 3 | 2010 | 1243 | 0.230 |
Why?
|
Radiation Injuries, Experimental | 1 | 2003 | 87 | 0.220 |
Why?
|
Heart Injuries | 1 | 2005 | 205 | 0.220 |
Why?
|
Muscle Cells | 1 | 2004 | 194 | 0.220 |
Why?
|
Hydroxamic Acids | 2 | 2003 | 484 | 0.220 |
Why?
|
Antifibrinolytic Agents | 3 | 2010 | 261 | 0.220 |
Why?
|
Intestinal Mucosa | 2 | 2017 | 2988 | 0.210 |
Why?
|
Heart | 4 | 2011 | 4361 | 0.200 |
Why?
|
Enzyme Activation | 6 | 2010 | 3601 | 0.200 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2002 | 237 | 0.200 |
Why?
|
Random Allocation | 7 | 2010 | 2385 | 0.200 |
Why?
|
Microdialysis | 6 | 2011 | 161 | 0.190 |
Why?
|
Enzyme Inhibitors | 5 | 2005 | 3695 | 0.190 |
Why?
|
Arrhythmias, Cardiac | 2 | 2010 | 2224 | 0.190 |
Why?
|
Temperature | 2 | 2006 | 2191 | 0.190 |
Why?
|
Ventricular Pressure | 3 | 2010 | 201 | 0.180 |
Why?
|
Biocompatible Materials | 1 | 2008 | 1682 | 0.180 |
Why?
|
Animals | 50 | 2011 | 166308 | 0.170 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2010 | 188 | 0.170 |
Why?
|
Serine Proteinase Inhibitors | 2 | 2011 | 175 | 0.170 |
Why?
|
Disease Models, Animal | 18 | 2010 | 17831 | 0.170 |
Why?
|
Collagen | 10 | 2011 | 2616 | 0.160 |
Why?
|
Enzyme Induction | 4 | 2006 | 455 | 0.160 |
Why?
|
Tranexamic Acid | 2 | 2010 | 151 | 0.150 |
Why?
|
Isoenzymes | 4 | 2006 | 1693 | 0.150 |
Why?
|
Cardiopulmonary Bypass | 3 | 2010 | 1062 | 0.140 |
Why?
|
Hemodynamics | 10 | 2010 | 4187 | 0.140 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2010 | 1173 | 0.140 |
Why?
|
Promoter Regions, Genetic | 5 | 2010 | 5761 | 0.140 |
Why?
|
Computer Simulation | 1 | 2010 | 6148 | 0.130 |
Why?
|
Hookworm Infections | 1 | 2015 | 16 | 0.130 |
Why?
|
Caspases | 3 | 2010 | 879 | 0.130 |
Why?
|
Endothelins | 2 | 2006 | 133 | 0.130 |
Why?
|
Echocardiography | 6 | 2010 | 4909 | 0.120 |
Why?
|
Peptides | 2 | 2006 | 4312 | 0.120 |
Why?
|
Rewarming | 2 | 2004 | 62 | 0.120 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 451 | 0.120 |
Why?
|
Cardioplegic Solutions | 2 | 2004 | 121 | 0.120 |
Why?
|
Transglutaminases | 1 | 2015 | 195 | 0.110 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 408 | 0.110 |
Why?
|
Catheter Ablation | 2 | 2005 | 2713 | 0.110 |
Why?
|
Enterocytes | 1 | 2015 | 219 | 0.110 |
Why?
|
Heart Failure | 5 | 2010 | 11085 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2010 | 2058 | 0.110 |
Why?
|
Alanine Transaminase | 1 | 2015 | 594 | 0.100 |
Why?
|
Tight Junctions | 1 | 2015 | 309 | 0.100 |
Why?
|
Fibroblasts | 4 | 2010 | 4039 | 0.100 |
Why?
|
Mice | 20 | 2011 | 80065 | 0.100 |
Why?
|
Fibrinolysis | 2 | 2010 | 323 | 0.100 |
Why?
|
Heart Ventricles | 7 | 2010 | 3772 | 0.100 |
Why?
|
Probiotics | 1 | 2015 | 357 | 0.100 |
Why?
|
Sus scrofa | 3 | 2010 | 426 | 0.090 |
Why?
|
Protease Inhibitors | 2 | 2006 | 750 | 0.090 |
Why?
|
GTP-Binding Proteins | 1 | 2015 | 946 | 0.090 |
Why?
|
Durapatite | 1 | 2011 | 156 | 0.090 |
Why?
|
Heart Rate | 3 | 2010 | 4039 | 0.090 |
Why?
|
Systole | 2 | 2010 | 928 | 0.090 |
Why?
|
Diastole | 2 | 2010 | 775 | 0.090 |
Why?
|
Time Factors | 12 | 2010 | 39589 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1585 | 0.080 |
Why?
|
Compliance | 1 | 2009 | 100 | 0.080 |
Why?
|
Acetylcysteine | 1 | 2010 | 262 | 0.080 |
Why?
|
Heart Septal Defects | 1 | 2010 | 189 | 0.080 |
Why?
|
Metalloendopeptidases | 3 | 2005 | 393 | 0.080 |
Why?
|
Calpain | 1 | 2009 | 146 | 0.080 |
Why?
|
Dilatation, Pathologic | 3 | 2010 | 516 | 0.080 |
Why?
|
Cardiotonic Agents | 2 | 2009 | 533 | 0.080 |
Why?
|
beta-Galactosidase | 2 | 2006 | 571 | 0.080 |
Why?
|
Thoracotomy | 1 | 2010 | 358 | 0.080 |
Why?
|
Immunohistochemistry | 8 | 2011 | 11037 | 0.080 |
Why?
|
Up-Regulation | 4 | 2010 | 4115 | 0.080 |
Why?
|
Microspheres | 1 | 2011 | 782 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2017 | 3134 | 0.080 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2010 | 855 | 0.080 |
Why?
|
Microinjections | 1 | 2008 | 322 | 0.080 |
Why?
|
Injections, Intralesional | 1 | 2008 | 276 | 0.070 |
Why?
|
Dipeptides | 1 | 2009 | 405 | 0.070 |
Why?
|
Atrial Fibrillation | 1 | 2006 | 5050 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1055 | 0.070 |
Why?
|
Dogs | 2 | 2010 | 3820 | 0.070 |
Why?
|
Protein Kinase C-epsilon | 1 | 2006 | 43 | 0.070 |
Why?
|
Probability | 2 | 2010 | 2468 | 0.070 |
Why?
|
Vaccines | 1 | 2015 | 817 | 0.070 |
Why?
|
Chemokines | 1 | 2010 | 955 | 0.070 |
Why?
|
Food Hypersensitivity | 1 | 2014 | 687 | 0.070 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2006 | 59 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1068 | 0.070 |
Why?
|
Hemostatics | 1 | 2009 | 234 | 0.070 |
Why?
|
Myocardial Reperfusion | 2 | 2006 | 346 | 0.070 |
Why?
|
Vasoconstriction | 1 | 2009 | 595 | 0.070 |
Why?
|
Extracellular Matrix | 2 | 2011 | 1710 | 0.070 |
Why?
|
Transforming Growth Factor beta | 2 | 2010 | 1945 | 0.070 |
Why?
|
Connexin 43 | 1 | 2006 | 201 | 0.060 |
Why?
|
Hyperkalemia | 2 | 2004 | 224 | 0.060 |
Why?
|
Stroke Volume | 5 | 2010 | 5139 | 0.060 |
Why?
|
Mice, Transgenic | 5 | 2010 | 9441 | 0.060 |
Why?
|
Pacemaker, Artificial | 1 | 2010 | 807 | 0.060 |
Why?
|
Isotonic Solutions | 1 | 2004 | 118 | 0.060 |
Why?
|
Sheep | 4 | 2011 | 1435 | 0.060 |
Why?
|
Male | 28 | 2017 | 351098 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1004 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 1958 | 0.060 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2003 | 138 | 0.060 |
Why?
|
Reference Values | 2 | 2008 | 4875 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3655 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2777 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7935 | 0.050 |
Why?
|
Depression, Chemical | 1 | 2002 | 184 | 0.050 |
Why?
|
Guanidines | 1 | 2003 | 191 | 0.050 |
Why?
|
Calcium Chloride | 3 | 2010 | 78 | 0.050 |
Why?
|
Endocardium | 1 | 2003 | 250 | 0.050 |
Why?
|
Adrenomedullin | 1 | 2002 | 86 | 0.050 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 2002 | 45 | 0.050 |
Why?
|
Gene Deletion | 3 | 2006 | 2662 | 0.050 |
Why?
|
Radio Waves | 1 | 2003 | 250 | 0.050 |
Why?
|
Recovery of Function | 2 | 2010 | 2924 | 0.050 |
Why?
|
Humans | 21 | 2020 | 746070 | 0.050 |
Why?
|
Creatine Kinase | 1 | 2003 | 688 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3509 | 0.050 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1285 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2010 | 6220 | 0.050 |
Why?
|
Blood Pressure | 4 | 2010 | 8405 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 2 | 2011 | 42 | 0.050 |
Why?
|
Sulfones | 1 | 2003 | 439 | 0.050 |
Why?
|
Disease Progression | 7 | 2006 | 13302 | 0.040 |
Why?
|
Aging | 2 | 2009 | 8485 | 0.040 |
Why?
|
Female | 20 | 2017 | 382129 | 0.040 |
Why?
|
Heart Atria | 1 | 2006 | 1321 | 0.040 |
Why?
|
Cicatrix | 1 | 2005 | 769 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2006 | 18891 | 0.040 |
Why?
|
Electrocardiography | 2 | 2010 | 6321 | 0.040 |
Why?
|
Infusions, Intravenous | 3 | 2010 | 2206 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2010 | 21529 | 0.040 |
Why?
|
Protein Transport | 1 | 2005 | 1962 | 0.040 |
Why?
|
Kidney | 4 | 2011 | 6984 | 0.040 |
Why?
|
Hypothermia, Induced | 1 | 2004 | 751 | 0.040 |
Why?
|
Quadriceps Muscle | 2 | 2010 | 149 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2010 | 14537 | 0.040 |
Why?
|
Ethanol | 1 | 2005 | 1316 | 0.040 |
Why?
|
Organ Size | 1 | 2003 | 2239 | 0.040 |
Why?
|
Fibrosis | 3 | 2010 | 2005 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 2 | 2010 | 683 | 0.040 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 2 | 2010 | 71 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2005 | 2247 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2011 | 12742 | 0.040 |
Why?
|
Caspase 3 | 2 | 2010 | 729 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17435 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10591 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4010 | 0.030 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2005 | 1245 | 0.030 |
Why?
|
Area Under Curve | 2 | 2010 | 1601 | 0.030 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2009 | 132 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2002 | 962 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 294 | 0.030 |
Why?
|
Actins | 3 | 2010 | 2051 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2020 | 636 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 63664 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 19804 | 0.030 |
Why?
|
Models, Animal | 2 | 2011 | 2111 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2141 | 0.030 |
Why?
|
Cell Survival | 1 | 2004 | 5759 | 0.030 |
Why?
|
Stress, Mechanical | 2 | 2009 | 1653 | 0.030 |
Why?
|
Genes, Reporter | 2 | 2009 | 1531 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 519 | 0.030 |
Why?
|
HLA-DQ Antigens | 1 | 2014 | 207 | 0.030 |
Why?
|
Angiotensin II | 2 | 2009 | 867 | 0.030 |
Why?
|
Troponin I | 2 | 2010 | 623 | 0.030 |
Why?
|
Postoperative Period | 2 | 2010 | 1804 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2011 | 10719 | 0.030 |
Why?
|
Mitral Valve Insufficiency | 1 | 2002 | 1404 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 1688 | 0.030 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2011 | 101 | 0.020 |
Why?
|
Middle Aged | 8 | 2017 | 214419 | 0.020 |
Why?
|
Thallium Radioisotopes | 1 | 2011 | 138 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4576 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2011 | 147 | 0.020 |
Why?
|
Survival | 1 | 2011 | 159 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 984 | 0.020 |
Why?
|
Fibrillar Collagens | 1 | 2010 | 41 | 0.020 |
Why?
|
Intestine, Small | 1 | 2017 | 1186 | 0.020 |
Why?
|
Ultrasonography | 3 | 2010 | 5895 | 0.020 |
Why?
|
Calcium | 1 | 2003 | 5654 | 0.020 |
Why?
|
Th17 Cells | 1 | 2017 | 768 | 0.020 |
Why?
|
Coronary Disease | 1 | 2005 | 5924 | 0.020 |
Why?
|
Gelatinases | 1 | 2010 | 89 | 0.020 |
Why?
|
Enzyme Precursors | 1 | 2010 | 174 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1821 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2906 | 0.020 |
Why?
|
Microbubbles | 1 | 2010 | 127 | 0.020 |
Why?
|
Lac Operon | 1 | 2009 | 237 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 11941 | 0.020 |
Why?
|
Microscopy, Confocal | 2 | 2005 | 1972 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6505 | 0.020 |
Why?
|
Myosins | 1 | 2010 | 402 | 0.020 |
Why?
|
Injections | 1 | 2011 | 830 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2015 | 1659 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2009 | 660 | 0.020 |
Why?
|
Mice, Knockout | 3 | 2011 | 14212 | 0.020 |
Why?
|
Elastin | 1 | 2009 | 300 | 0.020 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2010 | 411 | 0.020 |
Why?
|
Chronic Disease | 1 | 2003 | 9114 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20145 | 0.020 |
Why?
|
Apoptosis | 3 | 2009 | 9425 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3408 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1375 | 0.020 |
Why?
|
Elasticity | 1 | 2009 | 651 | 0.020 |
Why?
|
Signal Transduction | 4 | 2011 | 23115 | 0.020 |
Why?
|
Adult | 5 | 2017 | 214969 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2006 | 242 | 0.020 |
Why?
|
Troponin | 1 | 2010 | 513 | 0.020 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2005 | 43 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2006 | 405 | 0.020 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2005 | 14 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2005 | 34 | 0.020 |
Why?
|
Gap Junctions | 1 | 2006 | 229 | 0.020 |
Why?
|
Heart Block | 1 | 2006 | 391 | 0.020 |
Why?
|
Aged | 5 | 2017 | 164222 | 0.020 |
Why?
|
Organ Specificity | 1 | 2009 | 1949 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2841 | 0.010 |
Why?
|
Liver | 2 | 2010 | 7371 | 0.010 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2011 | 974 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2005 | 531 | 0.010 |
Why?
|
Age Factors | 2 | 2013 | 18145 | 0.010 |
Why?
|
Heart Septum | 1 | 2005 | 294 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3426 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2015 | 21676 | 0.010 |
Why?
|
Creatine Kinase, MB Form | 1 | 2003 | 209 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2004 | 346 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1892 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 3011 | 0.010 |
Why?
|
Benzenesulfonates | 1 | 2003 | 165 | 0.010 |
Why?
|
Electrolytes | 1 | 2004 | 280 | 0.010 |
Why?
|
Hematologic Tests | 1 | 2004 | 235 | 0.010 |
Why?
|
Heart Function Tests | 1 | 2003 | 317 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5048 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4783 | 0.010 |
Why?
|
Chymases | 1 | 2002 | 73 | 0.010 |
Why?
|
Cell Hypoxia | 1 | 2005 | 659 | 0.010 |
Why?
|
Angiotensin I | 1 | 2002 | 55 | 0.010 |
Why?
|
Alabama | 1 | 2002 | 103 | 0.010 |
Why?
|
Xanthines | 1 | 2002 | 120 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 516 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15539 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3549 | 0.010 |
Why?
|
Immunoblotting | 1 | 2005 | 1649 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2006 | 939 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2004 | 15341 | 0.010 |
Why?
|
Kinetics | 1 | 2009 | 6354 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6453 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2006 | 1483 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8593 | 0.010 |
Why?
|
Renin | 1 | 2002 | 637 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 2074 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 2003 | 648 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10278 | 0.010 |
Why?
|
Cell Separation | 1 | 2004 | 1718 | 0.010 |
Why?
|
Cell Communication | 1 | 2006 | 1628 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2005 | 1824 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12839 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 57114 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 12985 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6213 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2003 | 1633 | 0.010 |
Why?
|
Infant | 2 | 2010 | 35448 | 0.010 |
Why?
|
Coronary Circulation | 1 | 2003 | 1559 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2003 | 1349 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4335 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 2820 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2002 | 1014 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5251 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2003 | 1109 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 7579 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2015 | 78293 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4863 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15306 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 1508 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2004 | 1919 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13493 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8904 | 0.010 |
Why?
|
Protein Binding | 1 | 2006 | 9280 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13798 | 0.010 |
Why?
|
Survival Analysis | 1 | 2006 | 10127 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17674 | 0.010 |
Why?
|
Piperazines | 1 | 2003 | 2469 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23681 | 0.010 |
Why?
|
Wound Healing | 1 | 2003 | 2748 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2003 | 2200 | 0.010 |
Why?
|
Macrophages | 1 | 2006 | 5648 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4590 | 0.010 |
Why?
|
Length of Stay | 1 | 2004 | 6292 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 86212 | 0.000 |
Why?
|
United States | 1 | 2015 | 70368 | 0.000 |
Why?
|
Phenotype | 1 | 2004 | 16250 | 0.000 |
Why?
|
Risk Factors | 1 | 2013 | 72413 | 0.000 |
Why?
|
Prospective Studies | 1 | 2004 | 53219 | 0.000 |
Why?
|